Hair shedding is a discussed effect of the GLP-1 class. The mechanism is not the compound itself but rapid caloric deficit with protein and micronutrient gaps. Data from published sources.
GLP-1 trials (semaglutide, tirzepatide) recorded telogen effluvium in a subset of participants. The driver is rapid weight loss with protein and micronutrient deficit — not a direct follicle action.
Higher than placebo in trials, but not clinically significant for most participants.
Telogen effluvium is typically reversible when nutritional status recovers.
Protein, iron, zinc, biotin — the standard set for rapid caloric deficit.
Full dossier: encyclopedia · Russian version: тирзепатид и волосы.
Telogen effluvium is generally reversible in described cases once nutrients recover.
Fact: telogen effluvium appeared in GLP-1 trials. Hypothesis: a direct compound mechanism.